Australia - engelsk - Department of Health (Therapeutic Goods Administration)

corin australia pty ltd - 43167 - acetabular shell - the trinity-i? plus acetabular device is a hemispherical press fit titanium alloy shell for use with ceramic, cobalt chrome alloy or polyethylene liners and a dedicated range of ceramic and cobalt chrome alloy modular 12/14 taper femoral heads. the trinity-i? plus acetabular system is intended for use in primary and revision tha in skeletally mature patients, to provide increased mobility and reduce pain by replacing the damaged hip joint articulation when there is evidence of sufficient sound bone to seat and support the components.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

signature orthopaedics pty ltd - 43167 - acetabular shell - the acetabular cup is for cementless use and is made of ti6al4v alloy with porous and ha coating and is coupled with a liner. the logical acetabular cup is intended to replace a hip joint where bone stock is sufficient to support the implant and are indicated for: non-inflammatory degenerative joint disease including osteoarthritis or avascular necrosis; inflammatory joint disease including rheumatoid arthritis (excluding tsi stem); correction of functional deformity including congenital hip dysplasia; traumatic injury involving the hip joint including traumatic arthritis or femoral head or neck fracture; failed previous hip surgery including internal fixation or joint fusion, reconstruction, hemiarthroplasty, surface replacement, or total replacement.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - lenalidomide, quantity: 5 mg - capsule - excipient ingredients: colloidal anhydrous silica; pregelatinised starch; sodium stearylfumarate; croscarmellose sodium; microcrystalline cellulose; titanium dioxide; gelatin; propylene glycol; ethanol; butan-1-ol; purified water; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - multiple myeloma (mm),lenalidomide viatris is indicated for the treatment of multiple myeloma.,myelodysplastic syndromes (mds),lenalidomide viatris is indicated for treatment of patients with transfusion-dependent anaemia due to low- or intermediate-1 risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.,mantle cell lymphoma (mcl),lenalidomide viatris is indicated for the treatment of patients with relapsed and/or refractory mantle cell lymphoma.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - lenalidomide, quantity: 25 mg - capsule - excipient ingredients: sodium stearylfumarate; pregelatinised starch; colloidal anhydrous silica; croscarmellose sodium; microcrystalline cellulose; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide; titanium dioxide; gelatin - multiple myeloma (mm),lenalidomide viatris is indicated for the treatment of multiple myeloma.,myelodysplastic syndromes (mds),lenalidomide viatris is indicated for treatment of patients with transfusion-dependent anaemia due to low- or intermediate-1 risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.,mantle cell lymphoma (mcl),lenalidomide viatris is indicated for the treatment of patients with relapsed and/or refractory mantle cell lymphoma.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - lenalidomide, quantity: 15 mg - capsule - excipient ingredients: pregelatinised starch; croscarmellose sodium; microcrystalline cellulose; sodium stearylfumarate; colloidal anhydrous silica; propylene glycol; butan-1-ol; isopropyl alcohol; iron oxide red; strong ammonia solution; simethicone; ethanol; shellac; sulfuric acid; titanium dioxide; gelatin - multiple myeloma (mm),lenalidomide viatris is indicated for the treatment of multiple myeloma.,myelodysplastic syndromes (mds),lenalidomide viatris is indicated for treatment of patients with transfusion-dependent anaemia due to low- or intermediate-1 risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.,mantle cell lymphoma (mcl),lenalidomide viatris is indicated for the treatment of patients with relapsed and/or refractory mantle cell lymphoma.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - lenalidomide, quantity: 10 mg - capsule - excipient ingredients: croscarmellose sodium; sodium stearylfumarate; colloidal anhydrous silica; pregelatinised starch; microcrystalline cellulose; titanium dioxide; indigo carmine; iron oxide yellow; gelatin; iron oxide black; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; potassium hydroxide - multiple myeloma (mm),lenalidomide viatris is indicated for the treatment of multiple myeloma.,myelodysplastic syndromes (mds),lenalidomide viatris is indicated for treatment of patients with transfusion-dependent anaemia due to low- or intermediate-1 risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.,mantle cell lymphoma (mcl),lenalidomide viatris is indicated for the treatment of patients with relapsed and/or refractory mantle cell lymphoma.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - pregabalin, quantity: 150 mg - capsule - excipient ingredients: maize starch; purified talc; hyprolose; titanium dioxide; purified water; iron oxide yellow; erythrosine; gelatin; sodium lauryl sulfate; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - pregabalin alphapharm (pregabalin) is indicated for the treatment of neuropathic pain in adults.,pregabalin alphapharm (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - pregabalin, quantity: 75 mg - capsule - excipient ingredients: hyprolose; purified talc; maize starch; titanium dioxide; purified water; iron oxide yellow; erythrosine; gelatin; sodium lauryl sulfate; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - pregabalin alphapharm (pregabalin) is indicated for the treatment of neuropathic pain in adults.,pregabalin alphapharm (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - pregabalin, quantity: 25 mg - capsule - excipient ingredients: maize starch; purified talc; hyprolose; titanium dioxide; purified water; iron oxide yellow; erythrosine; gelatin; sodium lauryl sulfate; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - pregabalin alphapharm (pregabalin) is indicated for the treatment of neuropathic pain in adults.,pregabalin alphapharm (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - pregabalin, quantity: 300 mg - capsule - excipient ingredients: maize starch; hyprolose; purified talc; titanium dioxide; purified water; iron oxide yellow; erythrosine; gelatin; sodium lauryl sulfate; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - pregabalin alphapharm (pregabalin) is indicated for the treatment of neuropathic pain in adults.,pregabalin alphapharm (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.